PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.

Bottero, Virginie; Santiago, Jose A; Potashkin, Judith A

Bottero, Virginie; Santiago, Jose A; Potashkin, Judith A.

Afiliación

Bottero V; Department of Cellular and Molecular Pharmacology, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Santiago JA; Department of Cellular and Molecular Pharmacology, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Potashkin JA; Department of Cellular and Molecular Pharmacology, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

J Parkinsons Dis ; 8(4): 529-537, 2018.

Article en En | MEDLINE | ID: mdl-30248063

Asunto(s)

Antígenos Comunes de Leucocito/sangre; Enfermedad de Parkinson/diagnóstico; Parálisis Supranuclear Progresiva/diagnóstico; Anciano; Diagnóstico Diferencial; Regulación hacia Abajo; Fosfatasas de Especificidad Dual/sangre; Femenino; Humanos; Estudios Longitudinales; Masculino; Enfermedad de Parkinson/sangre; Parálisis Supranuclear Progresiva/sangre

Palabras clave

PTPRC; Parkinson's disease; biomarkers; gene expression; phosphatase; progressive supranuclear palsy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Parálisis Supranuclear Progresiva / Antígenos Comunes de Leucocito Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: J Parkinsons Dis Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google